Designed to help clinicians understand cardiac amyloidosis, and help identify those who may be at risk, this tool includes links to heart failure, red flags for ATTR, a diagnostic algorithm, and related resources.

Supported by Pfizer, Inc.

Resource Details

Reviewed on

June 19, 2024

Language(s)

  • English
  • Spanish

Download Resource